Abivax S.A. Stock Analysis & AI Score
Abivax S.A. (ABVX) has an ST Score of 53.5 (B-), driven by its Sentiment (A+) and held back by its Growth (D-). Analysts rate it Buy with a $156.00 price target (+68.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIABVX Stock Price History
ABVX Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
ABVX Latest Stock News
ST Score
Abivax S.A. (ABVX) has an ST Score of 53.5 (B-), driven by its Sentiment (A+) and held back by its Growth (D-). Analysts rate it Buy with a $156.00 price target (+68.5% upside).
- Strongest
- SentimentA+
- Weakest
- GrowthD-
All factor grades
- SentimentA+
- ForecastA
- Financial StrengthB
- MomentumB
- ValuationB-
- ProfitabilityD
- GrowthD-
- Piotroski3/9
Press Releases
Company Contact Details
ABVX stock: frequently asked questions
What is ABVX's ST Score?
Abivax S.A. (ABVX) has an ST Score of 53.5 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ABVX a buy, hold, or sell?
Analysts rate ABVX a Buy, with a price target of $156.00 (+68.5% vs the current price). Our ST Score grades it B- (53.5/100). The ST Score is a data-driven signal, not a recommendation.
What are ABVX's factor grades?
Valuation B-, Profitability D, Financial Strength B, Momentum B, Growth D-, Forecast A, Sentiment A+.
What is ABVX's valuation grade?
Abivax S.A. (ABVX) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ABVX's growth grade?
Abivax S.A. (ABVX) earns a growth grade of D-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ABVX's profitability grade?
Abivax S.A. (ABVX) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ABVX's financial strength grade?
Abivax S.A. (ABVX) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ABVX?
The average analyst price target for Abivax S.A. (ABVX) is $156.00 from 13 analysts, which is +68.5% versus the recent price of $92.59.
What is ABVX's Piotroski score?
Abivax S.A. (ABVX) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.